Teb Bancorp Inc (TBBA PINK) stock market data APIs
$6.563
0(0%)
as of July 3, 2025
Try our APIs with
free plan!
Teb Bancorp Inc Financial Data Overview
Price chart is built with
Anychart
TEB Bancorp, Inc. operates as the bank holding company for The Equitable Bank, S.S.B. that provides a range of financial services in the Metropolitan Milwaukee area, southeastern Wisconsin. The company accepts deposits, such as savings, checking, and individual retirement accounts; and certificates of deposit, money markets, and health savings accounts. It also provides mortgage, portfolio, community lending, home equity, personal, leasing, and business loans; and investment, debit and credit cards, online and mobile banking, and business services. The company was founded in 1927 and is headquartered in Wauwatosa, Wisconsin. TEB Bancorp, Inc operates as a subsidiary of TEB MHC.
Prev. Close
6.563
Open
6.563
High
6.563
Low
6.563
52 wk Range
5.17-9.8
Market Cap
17 058 K
P/E Ratio
5.2846
Shares Outstanding
2 624 K
Revenue
9 878 K
EPS
-0.2329
Beta
0.211
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Teb Bancorp Inc data using free add-ons & libraries
Get Teb Bancorp Inc Fundamental Data
Teb Bancorp Inc Fundamental data includes:
- Net Revenue: 9 878 K
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-28
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Teb Bancorp Inc News
New
Marinus Enrolls First Patient in Pivotal Phase 3 Clinical Trial of IV Ganaxolone in Refractory Status Epilepticus
Marinus and Ceribell, Inc. agree to place handheld Ceribell Rapid Response EEG systems in hospitals in connection with its Phase 3 RSE clinical trial Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a p...
Marinus Pharmaceuticals Receives Positive Response from FDA on Sufficiency of One Phase 3 Clinical Trial for Filing of New Drug Application (NDA) for the Use of Ganaxolone in CDKL5 Deficiency Disorder (CDD)
Marinus is moving towards a pre-NDA meeting, targeted for the end of Q1, in support of NDA submission by the end of Q2 Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated...
Marinus Pharmaceuticals to Participate in 39th Annual J.P. Morgan Healthcare Conference and the H.C. Wainwright Bioconnect Conference
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced that company management ...
Marinus Pharmaceuticals Announces Its Addition to the Nasdaq Biotechnology Index
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced it has been selected for...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
